Aptevo Registers 6.4M Resale Shares from $4.5M Warrant Financing
APVO is trading near its 52-week low of $2.58 (3.9% above the low).
Summary
Aptevo filed an S-1 to register 6.44M shares underlying warrants from its recent $4.5M financing, making them tradable and creating a large potential overhang on the stock.
Key Events · Financing and Capital Events · APVO
-
6.44M Resale Shares Registered
S-1 registers 6,444,858 shares underlying pre-funded warrants, common warrants, and inducement warrants issued in the August 12, 2026 financing.
-
Three Institutional Sellers Named
Armistice Capital, Hudson Bay, and Sabby Volatility Warrant Master Fund are the selling stockholders, each holding over 2.1M shares.
-
Massive Potential Dilution
The 6.44M resale shares represent over 3.5x the current 1.81M shares outstanding, creating a significant overhang if exercised and sold.
-
Warrants Not Yet Exercisable
Common and inducement warrants require stockholder approval before exercise; pre-funded warrants are immediately exercisable.
Analysis · APVO · Life Sciences
This S-1 registers 6,444,858 shares for resale by three institutional investors (Armistice, Hudson Bay, Sabby) who received warrants in the August 12, 2026 financing. The registration makes these shares tradable, creating a significant overhang on the stock. With only 1.81M shares currently outstanding, the potential resale of 6.44M shares represents a massive increase in float. The company trades near its 52-week low at $2.68, and this registration adds selling pressure risk. However, the warrants are not yet exercisable until stockholder approval, and the company received $4.5M in proceeds from the original financing, which extends its cash runway.
At the time of this filing, APVO was trading at $2.68 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.8M. The 52-week trading range was $2.58 to $48.78. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.